Fig. 2
HIV-1 proviral DNA analysis from weeks 96 and 248 of the CHER trial. Y-axes represent HIV-1 proviral DNA (log10 copies per 106 PBMCs). Plot A: HIV-1 proviral DNA in ART-Def [n = 44, median 2415 (IQR 499–7450)] and ART-96 W (n = 73, median [325 (53–3670) copies of HIV-1 proviral DNA/106 PBMCs] at week 96 (p = 0.0019). Plot B: HIV-1 proviral DNA at week 96 by age of starting ART (n = 117). Plot C: HIV-1 proviral DNA in ART-Def (n = 70, ART-40 W (n = 56) and ART-96 W (n = 43) at 248 weeks (Kruskal–Wallis test p = 0.2553). Plot D: HIV-1 proviral DNA at week 248 by duration of ART received by 248 weeks. Plot E: HIV-1 proviral DNA at trial week 248 by weeks of continuous HIV-1 RNA suppression below 400 copies/ml